Reports on the decreased profits of British drug maker GlaxoSmithKline for the second quarter of 2004 due to generic competition and a weak dollar. Statements by the firm's chief executive Jean-Pierre Garnier; Sales performance of its antidepressants.
Processing Request
No Comments.